Targeting Mitochondria for Cancer Treatment
Authors:
- Ljubava D. ZorovaLZLjubava D. Zorova
- Polina A. AbramichevaPAPolina A. Abramicheva
- Nadezda V. AndrianovaNANadezda V. Andrianova
- Valentina A. BabenkoVBValentina A. Babenko
- Savva D. ZorovSZSavva D. Zorov
- Irina B. PevznerIPIrina B. Pevzner
- Vasily A. PopkovVPVasily A. Popkov
- Dmitry S. SemenovichDmitry S. Semenovich
- Elmira I. YakupovaEYElmira I. Yakupova
- Denis N. SilachevDenis N. Silachev
- Egor Y. PlotnikovEgor Y. Plotnikov
- Gennady T. SukhikhGSGennady T. Sukhikh
Open Access
- 23 March 2024
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (4) , 444
Abstract
There is an increasing accumulation of data on the exceptional importance of mitochondria in the occurrence and treatment of cancer, and in all lines of evidence for such participation, there are both energetic and non-bioenergetic functional features of mitochondria. This analytical review examines three specific features of adaptive mitochondrial changes in several malignant tumors. The first feature is characteristic of solid tumors, whose cells are forced to rebuild their energetics due to the absence of oxygen, namely, to activate the fumarate reductase pathway instead of the traditional succinate oxidase pathway that exists in aerobic conditions. For such a restructuring, the presence of a low-potential quinone is necessary, which cannot ensure the conventional conversion of succinate into fumarate but rather enables the reverse reaction, that is, the conversion of fumarate into succinate. In this scenario, complex I becomes the only generator of energy in mitochondria. The second feature is the increased proliferation in aggressive tumors of the so-called mitochondrial (peripheral) benzodiazepine receptor, also called translocator protein (TSPO) residing in the outer mitochondrial membrane, the function of which in oncogenic transformation stays mysterious. The third feature of tumor cells is the enhanced retention of certain molecules, in particular mitochondrially directed cations similar to rhodamine 123, which allows for the selective accumulation of anticancer drugs in mitochondria. These three features of mitochondria can be targets for the development of an anti-cancer strategy.Keywords
Funding Information
- Ministry of Health of Russian Federation (124013000594-1)
This publication has 203 references indexed in Scilit:
- Metabolic dysfunction and early‐onset colorectal cancer – how macrophages build the bridgeCancer Medicine, 2020
- Oxidative damage and amyloid‐β metabolism in brain regions of the longest‐lived rodentsJournal of Neuroscience Research, 2013
- Imaging pH and metastasisNMR in Biomedicine, 2011
- Effects of P-glycoprotein and Mrp2 inhibitors on the hepatobiliary disposition of Rhodamine 123 and its glucuronidated metabolite in isolated perfused rat liversJournal of Pharmaceutical Sciences, 2010
- Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cellsInternational Journal of Cancer, 2002
- An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors11Edited by J. ThorntonJournal of Molecular Biology, 2001
- Substrate Oxidation and ATP Supply in AS-30D Hepatoma CellsArchives of Biochemistry and Biophysics, 2000
- PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor, Facilitates the Induction of Apoptosis and Reverses Bcl-2-Mediated CytoprotectionExperimental Cell Research, 1998
- Interaction of molecular probes with living cells and tissues. Part 2Histochemistry and Cell Biology, 1990
- Conformational coupling in H+-pumps and ATP synthesis ? its analysis with anisotropic inhibitors of energy transduction in oxidative phosphorylationMolecular and Cellular Biochemistry, 1984